HK2 and cancer: Ciscato and colleagues [54] expanded on the knowledge of HK2 binding at the mitochondria in varying cancer models, including TNBC, by showing that HK2 localizes at the Mitochondria-Associated Membranes (MAMs), a contact site between the OMM of the mitochondria and the endoplasmic reticulum in vivo and in vitro.